Evidence map›Paper›PMID 42649867›Full record

ArticleCancers2026

NF-κB/Lipocalin 2 Signaling Pathway Mitigates the Chemoresistance of BRAFV600E-Mutant Colorectal Cancer to Cisplatin by Promoting Ferroptosis.

Meibao Feng, Xuesong Wu, Li Jiang, Jinyan Huang, Jing Zhang, Pei Chen, Chengdong Chang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meibao FengDepartment of Pathology, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
Xuesong WuDepartment of Pathology, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.ORCID 0000-0002-8101-832X
Li JiangLaboratory of Animal Research Center, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
Jinyan HuangBiomedical Big Data Center, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.ORCID 0000-0002-8053-0209
Jing ZhangDepartment of Pathology, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
Pei ChenDepartment of Pathology, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
Chengdong ChangDepartment of Pathology, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.

Funding

National Natural Science Foundation of China 82002488Zhejiang Provincial Natural Science Foundation LQ19H160038Zhejiang Provincial Natural Science Foundation LQ21H160020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosisBRAFV600Echemoresistancecolorectal cancerferroptosislipocalin 2

Identifiers

PMID42649867
PMCPMC13510473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.